FOCUS may lower PE diagnosis in ED patients with suspected PE and abnormal vitals

November 06, 2019

DES PLAINES, IL -- Focused cardiac ultrasound (FOCUS) performed by emergency physicians with advanced training in emergency ultrasound may significantly lower the likelihood of the diagnosis of pulmonary embolism (PE) in most patients who are suspected of PE and have abnormal vital signs. This was especially true in those patients with a heart rate > 110 beats/min. That is the conclusion of a study to be published in the November 2019 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).

The lead author of the prospective observational multicenter cohort study is James I. Daley MD, MS, MPH, an instructor in the Department of Emergency Medicine at Yale School of Medicine. Daley et. al suggest that further study in a larger cohort of patients (which would yield narrower 95% confidence intervals) is required before focused cardiac ultrasound can be used to reliably exclude pulmonary embolism in this patient population.

The results suggest that FOCUS can be an important tool in the initial evaluation of emergency department (ED) patients with suspected PE and abnormal vital signs.

Commenting on the study is Robert R. Ehrman, MD, MS, the director of emergency ultrasound research at Wayne State University School of Medicine/Detroit Medical Center in Detroit, MI:  

"This is an important study as it is the first to demonstrate that point-of-care echocardiography can meaningfully reduce the likelihood of pulmonary embolism when clinical suspicion is high, potentially obviating the need for CT scanning in some patients. Moreover, the skills required to perform this exam are within the scope of all Emergency Physicians and thus the potential benefits at the population level are immense."
-end-
ABOUT ACADEMIC EMERGENCY MEDICINE

Academic Emergency Medicine, the monthly journal of Society for Academic Emergency Medicine, features the best in peer-reviewed, cutting-edge original research relevant to the practice and investigation of emergency care. The above study is published open access and can be downloaded by following the DOI link: 10.1111/acem.13774. Journalists wishing to interview the authors may contact Stacey Roseen at sroseen@saem.org.

ABOUT THE SOCIETY FOR ACADEMIC EMERGENCY MEDICINE

SAEM is a 501(c)(3) not-for-profit organization dedicated to the improvement of care of the acutely ill and injured patient by leading the advancement of academic emergency medicine through education and research, advocacy, and professional development. To learn more, visit saem.org.

Society for Academic Emergency Medicine

Related Pulmonary Embolism Articles from Brightsurf:

Pulmonary artery thrombosis a complication of radiation therapy
According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize.

High risk of deep vein thrombosis and pulmonary embolism in patients with COVID-19
In a systematic review of the worldwide published data on ''Venous thromboembolism (VTE) in COVID-19 patients'', researchers from the Department of Medicine I (MedUni Vienna), provide an in-depth analysis on the risk of VTE in patients hospitalised for COVID-19.

Trial clarifies which patients with acute pulmonary embolism can be managed at home
Patients with acute pulmonary embolism can be selected for home management using the sPESI score or the Hestia criteria, according to results of the HOME-PE trial presented in a Hot Line session today at ESC Congress 2020.1 Principal investigator Professor Pierre-Marie Roy of the University Hospital of Angers, France said: ''The pragmatic Hestia method was at least as safe as the sPESI score for triaging haemodynamically stable pulmonary embolism patients for outpatient care.''

Barriers exist to using risk stratification tools to evaluate pulmonary embolism in the ED
Common barriers exist to the use of risk stratification tools in the evaluation of pulmonary embolism in the emergency department and provide insight into where to focus efforts for future implementation endeavors.

Pulmonary embolism and COVID-19
Researchers at Henry Ford Health System in Detroit say early diagnosis of a life-threatening blood clot in the lungs led to swifter treatment intervention in COVID-19 patients.

Is pulmonary rehab after hospitalization for COPD associated with better survival?
Claims data for nearly 200,000 Medicare patients were used to examine the association between starting pulmonary rehabilitation within 90 days of being hospitalized for chronic obstructive pulmonary disease (COPD) and survival after one year.

Short or long sleep associated with Pulmonary Fibrosis
Scientists have discovered that people who regularly sleep for more than 11 hours or less than 4 hours are 2-3 times more likely to have the incurable disease, pulmonary fibrosis, compared to those that sleep for 7 hours in a day.

Better way to interpret blood tests to diagnose pulmonary embolism
A study led by Hamilton researchers has found a new way to interpret blood test results in patients who are investigated for blood clots in their lungs, a condition known as pulmonary embolism.

Reversed halo signs manifest in septic pulmonary embolism due to IV drug use
According to an article published ahead-of-print in the January 2020 issue of the American Journal of Roentgenology (AJR), reversed halo signs were frequently observed on the chest CT scans of patients with IV substance use disorder-related septic pulmonary embolism.

Treating pulmonary embolism: How safe and effective are new devices?
A new scientific statement from the American Heart Association identifies the risks and benefits of novel interventional devices compared to anticoagulation alone in the treatment of patients with pulmonary embolism.

Read More: Pulmonary Embolism News and Pulmonary Embolism Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.